Capsuleers.app logo CAPSULEERS.APP
CorporationActive

[2.O] Scholastic Pursuits

27 membersTax 6%Founded in 2015
CEOMisxashiIndependent
Kills
78
+0 in the last 90 days
Losses
86
+0 in the last 90 days
48%
Efficiency
ISK Efficiency 47%
ISK destroyed
5.53B
+0 in the last 90 days
Activity
Inactive
0 kills/day · last 90 days

Combat Record

Career-long numbers from eve-kill

Combat

Kills
78
Losses
86
Danger Ratio
97%
Final Blows
76
Points
78

ISK

Destroyed
5.53B
Lost
6.13B
Balance
-596.0M
ISK Efficiency
47%

Solo

Solo Kills
67
Solo Ratio
86%
Avg Kills/Day
—

Other

NPC Losses
3
NPC Loss Ratio
3%
Activity
Inactive

Activity

What the corporation flies, where it fights, latest kills and losses

ShipsLast 90d
SystemsLast 90d
Latest killsKillboard
Latest lossesKillboard

Most Valuable

The priciest kills in the window

Matchups

Who they kill, who kills them, what they lose

Last 90d
Killed
Killed By
Hulls LostLosses broken down by hull class.

Battles

Engagements in the selected window, from our own killmail archive

Description

-Scholastic Pursuits-

PvP corporation powered by strong PvE

We are seeking like-minded players. If you are a PvE player that wants to get into occasional PvP roams then apply now. There are no obligations; you're not forced to, or graded on whether or not you show up for PvP, simply join up our weekly gangs if you feel like going out for a roam, or to take a break from PvE.

We have helpful players willing to offer assistance to new players and further their EvE experience. We can help you learn pretty much all EvE content, from how to survive in WH, low/null, to the basics such as establishing stable income and managing losses.

-Now with Orca mining support!

We use TS3 to organize roams and activities, as well as to hang out.

-
Our philosophy is PvP habits afforded by healthy PvE income.

*
Note: You will be drug tested within 48 hours of hiring as compliant with Federal and State laws

*
public chat: SPursuits
*
Mostly US Timezone, but all are welcome. Some players play into Aussie timezone.